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Conversely to cystic ﬁbrosis (CF) diagnosis based on symptoms, in CF newborn
screening (NBS) programmes, initial parent information on CF and follow-up care
are incorporated into family life very early.
Aim: To assess the knowledge of preschool age CF (PSA-CF) patients and the
information parents believe the children understand.
Method: Over a three-month period, face-to-face interviews and questionnaires
were conducted by a psychologist with the parents and with PSA-CF patients born
between 2002 and 2006.
Results: 22 children (13F, 9M) out of 24 were included as well as 4 fathers,
14 mothers and 4 couples. 16 children were able to understand the questions (mean
age 4 years). No parental refusal was observed. Parents believe the child was aware
of the reason for the hospital visit in 94%, could cite “CF” in 62% and its genetic
aetiology in 6%. In fact the actual results in children were 62%, 44% and 6%.
Some 62% of parents and children expressed a desire for more information and
up to 95% for educational resources. For parents the ideal age for CF disclosure
ranged from infant to 8 y with a mean at 3.7 y. Children cope adequately with their
daily treatment, hospital visits and chest physiotherapy in 76%, 70% and 63%.
Conclusion: Findings highlight discrepancies between PSA-CF patients’ knowledge
of their disease and parents perceptions. We emphasize the need for improving
therapeutic education in patients’ age range.
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Introduction: The UK CF Gene Therapy Consortium (funded by the CF Trust)
is preparing for a multi-dose gene therapy trial which may produce some clinical
beneﬁts.
Aims: The current study explores the expectations of CF patients involved in the
pre-treatment phase of this gene therapy trial (the “Run-in study”), from which
participants will be selected for the multi-dose gene therapy trial.
Method: Semi-structured interviews were conducted with twelve participants (six
with mild and six with moderate CF). Interviews were recorded, transcribed
verbatim and analysed using a Constructivist Grounded Theory approach.
Results: The reality of clinical beneﬁt from gene therapy is growing for participants
as they progress through the Run-in study. Most participants hoped for personal
beneﬁt from the gene therapy trial, with half also acknowledging that they were
closer to expecting tangible outcomes. All participants but one expressed the hope
of being selected for the actual gene therapy trial. Participants generally managed
these expectations well, although those with late diagnosis found this more difﬁcult.
Conclusion: Participants in the Run-in trial are largely positive about being involved
in the gene therapy trial. Levels of optimism about personal beneﬁt from the trial
exceeded those found in earlier studies. Some of these positive expectations are
unlikely to be met by the gene therapy trial. However, others participated with
apparently realistic expectations and some would probably have participated even
without prospect for personal beneﬁt. Psychological support may be required for
those not selected to continue on to the gene therapy trial.
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Adherence to treatment is inﬂuenced by many factors and is critical to optimal CF
management. Psychosocial factors are emerging as strong predictors of adherence
behaviour.
Aim: To explore personality, psychosocial and socioeconomic factors and their
association with adherence behaviour in CF patients.
Methodology: Demographic, health related measures, socioeconomic, and ques-
tionnaires investigating personality (NEO-PI), psychosocial (depression, anxiety,
social support, health locus of control, life stressors, quality of life and health
beliefs) and adherence behaviour [Morisky Score and Beliefs and Behaviour Ques-
tionnaire (BBQ)] were obtained at the commencement of electronically monitored
treatment with azithromycin.
Results: To date 67 participants (mean years = 33.9 yrs, SD= 9.7 range 20−68)
males 53%, mean FEV1 % predicted = 57.2 SD= 20.6, range 19–115) have
been recruited. A signiﬁcant correlation was observed between Morisky score
and BBQ self-reported adherence measures (r2 = 0.27, p< 0.01). The psychosocial
factors that were related to reported adherence were consciousness (r2 = 0.45,
p< 0.001), anxiety (r2 = 0.25 p< 0.001) anxiety and depression (r2 = −0.25 p< 0.04)
and stressful life events (r2 = 0.25 p< 0.001). Using census-derived (SEFIA) data,
FEV1 % predicted at baseline was dependent on socio-economic status scores
(r2 = 0.27, p< 0.03). In addition, FEV1% predicted was dependent on education
and occupation scores (r2 = 0.33, p< 0.009).
Conclusion: Skilled assessment and consideration of multiple psychological factors
may be beneﬁcial in optimizing adherence to treatment plans in CF patients.
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Poor concordance with medical treatment is common in chronic illnesses, including
CF. The reasons for poor concordance are not well understood. The application
of theoretical models have met with limitted success. Abbott et al found some
support for the “health locus of control” model but not the “health belief” model.
New models suggest that “illness representations” are linked with concordance.
Weinmann et al developped the brief illness perception questionnaire, scores have
been shown to be linked to health behaviours in other conditions.
Methods: All 115 adult CF patients attending our clinic were invited to take part.
Participants were asked to complete an anonymous questionnaire whilst attending
clinic or at home. Concordance was measured by disclosing how often each
treatment was taken on the following scale: always; most of the time; occasionally
or never. The brief illness perception questionaire was then completed. Basic patient
demographics and the reasons for poor concordance were also recorded.
Results: 64 patients took part. Reported concordance was highest for azithromycin
and creon followed by vitamins and nebulised antibiotics. Concordance was lowest
for supplementary feeds. Illness perception was not linked to poor concordance for
any of the treatments. Those with children or in the 18 to 25 year age group were
more likely to have poor concordance. Forgetfulness was the commonest reason
cited for non-concordance.
Conclusions: These results suggest that illness perception is similar amongst those
who comply with their treatment and those who do not, challenging our ideas of
what inﬂuences patient concordance.
